Standards for autoantibody testing; Addressing future needs for autoimmune disease and cancer diagnosis

Cancer Biomarkers

Volumn 1, Issue 4-5, 2005, Pages 221-227

  Amos, Michael D ^a   Bridges, Alan J ^b  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b William S Middleton Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNE DISEASE; BLOOD; DIAGNOSTIC PROCEDURE; EVALUATION; FORECASTING; HUMAN; NEOPLASM; REVIEW; STANDARD;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; FORECASTING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; REFERENCE STANDARDS;

EID: 39049187081     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-14-504     Document Type: Article

References (30)

1. D. Leslie, P. Lipsky and A.L. Notkins, Autoantibodies as predictors of disease, J Clin Invest 108(10) (2001), 1417-1422.
2. Economic costs of diabetes in the US in 2002, Diabetes Care 26 (2003), 917-932.
3. F. Fernandez-Madrid, P.J. VandeVord, X. Yang, R.L. Karvonen, P.M. Simpson, M.J. Kraut, J.L. Granda and J.E. Tomkiel, Antinuclear antibodies as potential markers of lung cancer, Clinical Cancer Research 5 (1999), 1393-1400.
4. F.M. Brichory, D.E. Misek, A.-M. Yim, M.C. Krause, T.J. Giordano, D.G. Beer and S.M. Hanash, An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer, Proc Natl Acad Sci USA 98(17) (2001), 9824-9829.
5. F. Fernandez-Madrid, N. Tang, H. Alansari, J.L. Granda, L. Tait, K.C. Amirikia, M. Moroianu, X. Wang and R.L. Karvonen, Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer, Cancer Res 64(15) (2004), 5089-5096.
6. F. Fernandez Madrid, R.L. Karvonen, J. Ensley, M. Kraut, J.L. Granda, H. Alansari, N. Tang and J.E. Tomkiel, Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck, Cancer Detect Prev 29(1) (2005), 59-65.
7. B. Rapoport, G.D. Chazenbalk, J.C. Jaume and S.M. McLachlan, The thyrotropin receptor: interaction with thyrotropin and autoantibodies, Endocr Rev 19 (1998), 673-716.
8. J. George, M. Blank, Y. Levy, P. Meroni, M. Damianovich, A. Tincani and Y. Shoenfeld, Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome, Circulation 97 (1998), 900-906.
9. T.P. Greco, M.D. Amos, A.M. Conti-Kelly, J.D. Naranjo and J.W. Ijdo, Testing for the antiphospholipid syndrome: Importance of IgA anti-beta 2-glycoprotein I, Lupus 9(1) (2000), 33-41.
10. M. Waldman and M.P. Madaio, Pathogenic autoantibodies in lupus nephritis, Lupus 14(1) (2005), 19-24.
11. R.R.A. Coombs, A.E. Mourant and R.R. Race, A new test for the detection of weak and incomplete Rh agglutinins, Br J Exp Pathol 26 (1945), 255.
12. E.M. Tan, International cooperative activities in standardization of antinuclear antibodies, in: Manual Bioogical Markers of Disease, van Venrooij and Maini, eds, Klewer Academic Publishers, Boston, 1993, p.p.A1:1-5.
13. E.M. Tan, R.J. Fritzler, J.S. McDougal, F.C. McDuffie, R.M. Nakamura, M. Reichlin, C.B. Reiner, G.C. Sharp, P.H. Schur, M.R. Wilson and R.J. Winchester, Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La, Arthritis Rheum 25 (1982), 1003-1005.
14. WHO Expert Committee on Biological Standardization, 30th Report. WHO Technical Report Series No. 638, 1979, 14.
15. WHO Expert Committee on Biological Standardization, 50th Report. October 1999.
16. http://www.nibsc.ac.uk/catalog/standards/ifu/93-768ifu.pdf.
17. http://www.nibsc.ac.uk/catalog/standards/ifu/96-522ifu.pdf.
18. W.J. van Venrooij, P. Charles and R.N. Maini, The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases, J Immunol Methods 140 (1991), 181-189.
19. W.J. van Venrooij, R.N. Maini and the Consensus Finding Group for Autoantibodies, The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases, Clin Exp Rheumatol 10 (1992), 507-511.
20. K. James, A.B. Carpenter, L. Cook, R. Marchand and R.M. Nakamura, Development of the antinuclear and anticytoplasmic antibody consensus panel by the association of medical laboratory immunologists, Clinical and Diagnostic Laboratory Immunology 7(3) (2000), 436-443.
21. R.W. Lightfoot Jr, Cost effective use of laboratory tests in rheumatology, Bull Rheum Dis 46 (1997), 1-3.
22. W. Emlen and L. O'Neill, Clinical significance of antinuclear antibodies: comparison of diction with immunofluorescence and enzyme-linked immunosorbent assays, Arthritis Rheum 40 (1997), 1612-1618.
23. H.K. Sarakbi, B.M. Goodman and A.J. Bridges, Immunofluorescence and enzyme immunoassay antinuclear antibody testing in rheumatology referrals, J Rheumatol 28 (2001), M115.
24. M.E. Suarez-Almazor, L. Gonzalez-Lopez, J.I. Gamez-Nava, E. Belseck, C.J. Kendall and P. Davis, Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians, J Rheumatol 25(10) (1998), 1980-1985.
25. J.S. Smolen, G. Steiner and E.M. Tan, Standards of care: the value and importance of standardization, Arthritis Rheum 40 (1997), 410-412.
26. J.S. Smolen, B. Butcher, M.J. Fritzler, T. Gordon, J. Hardin, J.R. Kalden, R. Lahita, R.N. Maini, W. Reeves, M. Reichlin, N. Rothfield, Y. Takasaki, W.J. van Venrooij and E.M. Tan, Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and Western blotting, Arthritis Rheum 40 (1997), 413-418.
27. E.M. Tan, J.S. Smolen, J.S. McDougal, B.T. Butcher, D. Conn, R. Dawkins, M.J. Fritzler, T. Gordon, J.A. Hardin, J.R. Kalden, R.G. Lahita, R.N. Maini, N.F. Rothfield, R. Smeenk, Y. Takasaki, W.J. van Venrooij, A. Wiik, M. Wilson and J.A. Koziol, A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities, Arthritis Rheum 42 (1999), 455-464.
28. M.R. Lerner and J.A. Steitz, Antibodies to small nuclearRNAs complexed with proteins are produced by patients with systemic lupus erythematosus, Proc Natl Acad Sci 76 (1979), 5495-5499.
29. A. Kavanaugh, R. Tomar, J. Reveille, D.H. Solomon and H.A. Homburger, Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens, American College of Pathologists, Arch Pathol Lab Med 124(1) (2000), 71-81.
30. A. Reiff, H. Haubruck and M.D. Amos, Evaluation of a recombinant antigen enzyme-linked immunosorbent assay (ELISA) in the diagnostics of antinuclear antibodies (ANA) in children with rheumatic disorders, Clin Rheumatol 21(2) (2002), 103-107.